MedApp S.A. signed a partnership agreement for a new Digital Clinic service with Diagnostyka, the largest Polish chain of medical laboratories. Thanks to the cooperation, patients and doctors will have easier access to the tests performed by Diagnostyka and secure insight into their results in electronic form -via a computer or a mobile app.
“Establishing cooperation with the leader in laboratory diagnostics in Poland is for us an important stage in the development of Digital Clinic. Thanks to the aforementioned partnership, specialists from medical facilities will be able to directly and remotely refer a patient to a number of tests performed by Diagnostyka. Moreover, both doctors and patients will have easy and secure access to theirresults, provided with a special code,” comments Krzysztof Mędrala, CEO of MedApp S.A. “Leveraging our expertise in artificial intelligence, we are gradually expanding our offer for patients and physicians. We believe that solutions offered within the Digital Clinic will soon be anew standard in the area of providing medical services supported by modern technology, and cooperation with Diagnostyka brings us closer to this goal.”
Diagnostyka is Poland’s largest chain of medical laboratories and has the widest selection of tests. Itspecializes in providing professional diagnostic services at all stages -from the collection and transport of biological material to the delivery of the results of medical analyses. Diagnostyka performs approximately 100 milliontests annually for more than 16 million patients.
The Digital Clinic solution streamlines the functioning of small medical facilities, hospitals, as well as developed medical chains. MedApp’s innovative service enables comprehensive remote patient support-from making an appointment, to conducting it, to ordering tests and analyzing their results. This isespecially important in the era of the ongoing fight against the SARS-COV-2 pandemic.
The new MedApp service is an expansion of the existing array of tools and solutions available in the CarnaLife System application.
Read more See similar articles:
CarnaLife Holo with FDA (Food and Drugs Administration) certification for the US market!
We are proud to announce that our CarnaLile Holo technology for augmented reality imaging of medical data (interactive holograms) has received 510(k) Class II certification for the world’s largest and richest market for new technology and robotic technology.
MedApp after Q4 2022: continued development of digital medicine technology solutions and acquisition of new sales contacts
As in the previous quarters of 2022, the Company is observing an extension of sales processes in the Polish market, trying to shift sales activity to foreign markets. To this end, the Company has signed further distribution agreements for the CarnaLife Holo solution
We are looking for companies and individuals interested in distributing MedApp’s medical technology.
CarnaLife Holo is a breakthrough technology for 3D visualization of imaged medical data which supports the planning and performance of medical procedures. With the help of Microsoft’s HoloLens 2, the physician can see in real space a three-dimensional hologram reflecting the structure of the imaged anatomical area.